Mayo Clinic News Network

News Resources

Brian Kilen (@briankilen)

Activity by Brian Kilen

Brian Kilen (@briankilen) posted · Tue, Feb 10 9:06am · View  

Mayo Clinic Supports Google Effort to Provide Quick, Accurate Health Information

ROCHESTER, Minn. — When people have health questions, many turn to the Internet, and Google in particular, as the first stop for finding health information. Now, when users ask Google about common health conditions, they will get relevant medical facts up front. For example, a search for arthritis will show, up front, a few basic facts about arthritis and a definition.Google image of medical conditions on mobile phone To ensure quality and accuracy, teams of doctors including expert clinicians at Mayo Clinic have reviewed the facts, and have written succinct definitions for the conditions.

The goal of this new feature is to provide medical information in a digestible way and get basic answers quickly. Google will provide information about symptoms and treatments, and details about how common a condition is, whether it’s critical, if it’s contagious, what ages it affects, and more. It will also provide high-quality illustrations and a streamlined design that makes it easier to tap or click through to more in depth information on other sites.

MEDIA CONTACT: Brian Kilen, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu [...]

Click here to view the rest of the post

Login here to comment.

Brian Kilen (@briankilen) posted · Fri, Feb 6 10:34am · View  

Exact Sciences and Mayo Clinic Extend, Expand Collaboration to Continue Fighting Cancer through Advanced Screening

Unique Arrangement Aims to Build on the Success of Cologuard®

Exact Sciences Corp. (NASDAQ: EXAS) and Mayo Clinic today announced a five-year extension and expansion of their collaboration, broadening their efforts to develop screening, surveillance and diagnostic tests beyond colorectal cancer to address other diseases within the gastrointestinal tract.Cologuard stool DNA screening box

The amended agreement extends the collaboration for five more years with David Ahlquist, M.D., a Mayo Clinic gastroenterologist, and his lab at Mayo Clinic. Exact Sciences will continue to have rights to certain intellectual property, including patents, know-how and new markers.

Dr. John NoseworthyThe original June 11, 2009 agreement between Exact Sciences and Mayo Clinic led to the development of Cologuard, which the U.S. Food and Drug Administration (FDA) approved on August 11, 2014. Cologuard is the first and only FDA-approved stool DNA-based colorectal cancer screening test.

“This unique collaboration is producing powerful results,” said John Noseworthy, M.D., president and CEO of Mayo Clinic. “The success of our teams in developing Cologuard exemplifies what can happen when two organizations combine their expertise and unite toward a single goal.”

“By expanding our relationship with Mayo Clinic, we have an opportunity to build on our shared successes and continue looking for new opportunities to take on some of the deadliest forms of cancer,” said Kevin Conroy, CEO and chairman of Exact Sciences. “This collaboration and our ability to leverage both institutions’ distinctly different strengths is unique in American industry. But our ambitions cannot end with Cologuard. We expect our collaboration to continue producing breakthroughs that can change patients’ lives.”

MEDIA CONTACTS:

J.P. Fielder, Exact Sciences Corp.  (202) 746 6352  Jfielder@exactsciences.com

Brian Kilen, Mayo Clinic 507-284-5005 newsbureau@mayo.edu            

[...]

Click here to view the rest of the post

Login here to comment.

Brian Kilen (@briankilen) posted · Fri, Jan 30 9:36am · View  

Mayo Clinic Health Letter: Highlights from the January 2015 Issue

ROCHESTER, Minn. ― Here are highlights from the January issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit http://healthletter.mayoclinic.com/ or call toll-free for subscription information, 1-800-333-9037, extension 9771. Full newsletter text: Mayo Clinic Health Letter January 2015 (for journalists only).

Wrist fractures: Treatment decisions not always straightforward

wrist pain photo (2)Treatment decisions for wrist fractures quickly can become complicated, according to the January issue of Mayo Clinic Health Letter.

The wrist is made up of eight small bones at the base of the hand and two in the forearm ― the radius and ulna ― that connect the elbow to the wrist bones. Any one of these bones can be fractured; a wrist fracture is a widely variable injury.

One of the primary decisions is the choice between nonsurgical and surgical treatment. Sometimes the choice is clear, and sometimes it’s not. Factors to consider include overall health, lifestyle, ability to tolerate surgery and the desire for a fully functioning wrist. [...]

Click here to view the rest of the post

Login here to comment.

Brian Kilen (@briankilen) posted · Thu, Jan 15 4:44pm · View  

Mayo Clinic Signs Joint Venture Agreement with Hillhouse Capital Group

China collaboration with Hillhouse Capital strengthens Mayo Clinic’s mission to improve health care worldwide

Paul Limburg, M.D.

Paul Limburg, M.D.

Today, Mayo Clinic announced it has entered into a joint venture agreement with Hillhouse Capital to advance the quality of health care in China. By combining Mayo Clinic’s patient care, medical research and education with Hillhouse’s China expertise and healthcare industry partnerships, the collaboration establishes a new company to improve health care delivery and efficiency in China.

“We are excited to collaborate with Hillhouse to provide Mayo Clinic knowledge and guidance to improve the quality of health care to the people of China,” said Paul Limburg, M.D., Medical Director, Mayo Clinic Global Business Solutions. “Our collaboration with Hillhouse extends Mayo Clinic’s reach and is at the core of Mayo Clinic’s mission to inspire hope and healing to people everywhere.”

The new venture benefits from recent policy changes by Chinese regulators to encourage private investment in health care. Mayo Clinic and Hillhouse believe that this collaboration presents a unique opportunity to leverage Mayo Clinic’s valuable capabilities in medical technology and management and Hillhouse’s strong in-country knowledge to deliver high-quality health care services to Chinese healthcare providers and patients. [...]

Click here to view the rest of the post

Login here to comment.

Brian Kilen (@briankilen) posted · Tue, Dec 23 2014 · View  

Mayo Clinic Health Letter: Highlights from the December 2014 Issue

ROCHESTER, Minn. ― Here are highlights from the December issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit http://healthletter.mayoclinic.com/ or call toll-free for subscription information, 1-800-333-9037, extension 9771. Full newsletter text: Mayo Clinic Health Letter December 2014 (for journalists only).

Myths and facts about how medications affect older adults

pills for mchlOlder adults need to be especially vigilant about drug safety, according to the December issue of Mayo Clinic Health Letter. That’s because older adults are more likely to be taking more than one medication at a time. Interactions between drugs can cause side effects that might not occur if a drug were taken alone. And, physical changes in older adults can alter both the effectiveness of a medication and side effects, compared with what a younger adult might experience. [...]

Click here to view the rest of the post

Login here to comment.

Brian Kilen (@briankilen) posted · Tue, Dec 9 2014 · View  

Mayo Clinic and Techstars to Offer New Program Techstars++ to Health Care Entrepreneurs

Mayo Clinic hosting immersion program for innovative medical startups accelerating advances in patient care

ROCHESTER, Minn., — Mayo Clinic announced today a new collaboration with Techstars to offer the Techstars++ program. The Techstars++ program will bring together health care entrepreneurs and companies with Mayo Clinic to find innovative solutions to improve patient care at an accelerated pace. Mayo Clinic is the first to participate in this new program.

Techstars is a mentorship-driven accelerator program with a track record of helping to develop businesses, especially technology startups. The Techstars++ program offers companies from the Techstars portfolio of 500 alumni companies the opportunity to extend their Techstars experience by spending time on-site and engaging deeply with a corporation/organization - Mayo Clinic in this initial program. [...]

Click here to view the rest of the post

Login here to comment.

Brian Kilen (@briankilen) posted · Mon, Dec 1 2014 · View  

Mayo Clinic Cardiologist Wins GSK’s Discovery Fast Track Challenge to Investigate Anti-hypertensive Agents

John Burnett Jr., M.D., a Mayo Clinic cardiologist, has been selected as a winner of GSK’s 2014 Discovery Fast Track Challenge, which is designed to accelerate the translation of academic research into novel therapies. Dr. Burnett will work with scientists in GSK’s Discovery Partnerships with Academia (DPAc) and the Molecular Discovery Research teams to test their hypotheses and screen targets against GSK’s compound collection.

John Burnett Jr., MD

John Burnett Jr., MD

Active compounds could then form the basis of full drug discovery programs that may ultimately lead to innovative medicines for anti-hypertensive agents.

Dr. Burnett submitted one of 14 winning proposals, chosen from 428 entries from 234 universities and academic institutes from across 26 countries. Research between Mayo Clinic and GSK will focus on treatments for resistant hypertension.

“We see this as a huge need, clinically, and we think our screen could lead to a breakthrough drug for the treatment of resistant hypertension, which is growing worldwide,” said Dr. Burnett. [...]

Click here to view the rest of the post

Login here to comment.

Brian Kilen (@briankilen) posted · Wed, Nov 19 2014 · View  

Mayo Clinic Health Letter: Highlights from the November 2014 Issue

ROCHESTER, Minn. — Here are highlights from the November issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit http://www.healthletter.mayoclinic.com/ or call toll-free for subscription information, 1-800-333-9037, extension 9771. Full newsletter text: Mayo Clinic Health Letter November 2014 (for journalists only). Full special report text: Mayo Clinic Health Letter Special Report November 2014 (for journalists only).

New approaches for relief from irritable bowel syndrome

There are new approaches to manage the frustrating symptoms of irritable bowel syndrome (IBS), according to the November issue of Mayo Clinic Health Letter.

illustration of normal pancreas and related anatomyIBS is a common disorder of the large intestine (colon), characterized by abdominal pain that occurs before or along with diarrhea or constipation. Symptoms can vary widely. For many people, flares of diarrhea may last for a few days followed by periods of remission. Constipation may last for days or even months, along with intermittent diarrhea or normal bowel function. A small number of people with severe IBS have unbearable pain that is constant at times.

Multiple factors may contribute to the bowel dysfunction. The foundation of IBS therapy is developing lifestyle, exercise and diet changes that generally facilitate smooth bowel function. Treatment often includes working with a physician or other care provider to develop a plan for regular exercise and management of stress, anxiety and other psychological factors. [...]

Click here to view the rest of the post

Login here to comment.

Load More    

Loading information...